Abstract:Three new series of macrocyclic active site‐directed inhibitors of the Zika virus (ZIKV) NS2B–NS3 protease were synthesized. The compounds were characterized by enzyme kinetic measurements, crystallized in complex with the ZIKV protease and analyzed for their antiviral potency in cell culture. Three new series of macrocyclic active site‐directed inhibitors of the Zika virus (ZIKV) NS2B–NS3 protease were synthesized. First, attempts were made to replace the basic P3 lysine residue of our previously described inhibitors with uncharged and more hydrophobic residues. This provided numerous compounds with inhibition constants between 30 and 50 nM. A stronger reduction of the inhibitory potency was observed when the P2 lysine was replaced by neutral residues, all of these inhibitors possess Ki values >1 μM. However, it is possible to replace the P2 lysine with the less basic 3‐aminomethylphenylalanine, which provides a similarly potent inhibitor of the ZIKV protease (Ki = 2.69 nM). Crystal structure investigations showed that the P2 benzylamine structure forms comparable interactions with the protease as lysine. Twelve additional structures of these inhibitors in complex with the protease were determined, which explain many, but not all, SAR data obtained in this study. All individual modifications in the P2 or P3 position resulted in inhibitors with low antiviral efficacy in cell culture. Therefore, a third inhibitor series with combined modifications was synthesized; all of them contain a more hydrophobic d‐cyclohexylalanine in the linker segment. At a concentration of 40 μM, two of these compounds possess similar antiviral potency as ribavirin at 100 μM. Due to their reliable crystallization in complex with the ZIKV protease, these cyclic compounds are very well suited for a rational structure‐based development of improved inhibitors.

Development of a S-adenosylmethionine analog that intrudes the RNA-cap binding site of Zika methyltransferase

The conformational changes of Zika virus methyltransferase upon converting SAM to SAH

High-resolution RNA tertiary structures in Zika virus stem-loop A for the development of inhibitory small molecules

Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase

Structure-based screening and validation of bioactive compounds as Zika virus methyltransferase (MTase) inhibitors through first-principle density functional theory, classical molecular simulation and QM/MM affinity estimation

Investigation of novel 5ʹ-amino adenosine derivatives with potential anti-Zika virus activity

Unveiling the antiviral potential of Plant compounds from the Meliaceae family against the Zika virus through QSAR modeling and MD simulation analysis

Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity

High-throughput crystallographic fragment screening of Zika virus NS3 Helicase

Structure and Function of the Zika Virus Full-Length NS5 Protein

Synthesis and structural characterization of new macrocyclic inhibitors of the Zika virus NS2B–NS3 protease

Non-Nucleoside Lycorine-Based Analogs as Potential DENV/ZIKV NS5 Dual Inhibitors: Structure-Based Virtual Screening and Chemoinformatic Analysis

Discovery And Computational Analyses Of Novel Small Molecule Zika Virus Inhibitors

Discovery of dehydroandrographolide derivatives with C19 hindered ether as potent anti-ZIKV agents with inhibitory activities to MTase of ZIKV NS5

Structure-Based Macrocyclization of Substrate Analogue NS2B-NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses

Structure of the NS2B-NS3 protease from Zika virus after self-cleavage

5'-cap RNA/SAM mimetic conjugates as bisubstrate inhibitors of viral RNA cap 2'-O-methyltransferases

Identification and characterization of Zika virus NS5 RNA-dependent RNA polymerase inhibitors

Structural and dynamics characterization of the Zika virus NS2B using nuclear magnetic resonance and RosettaMP: A challenge for transmembrane protein studies

Structural insights into the Zika virus NS1 protein inhibition using a computational approach

Discovery and structural optimization of a new series of N-acyl-2-aminobenzothiazole as inhibitors of Zika virus